You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR BEROTRALSTAT HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for berotralstat hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03485911 ↗ Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE Active, not recruiting BioCryst Pharmaceuticals Phase 3 2018-02-06 This is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of oral BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II HAE.
NCT04933721 ↗ Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies Not yet recruiting BioCryst Pharmaceuticals Phase 3 2021-06-01 This is a phase 3b open-label study providing access to berotralstat for HAE patients who were previously enrolled in berotralstat studies.
NCT05392114 ↗ A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE) Not yet recruiting Ionis Pharmaceuticals, Inc. Phase 3 2022-05-01 The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for berotralstat hydrochloride

Condition Name

Condition Name for berotralstat hydrochloride
Intervention Trials
Hereditary Angioedema 4
HAE 2
Pediatric 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for berotralstat hydrochloride
Intervention Trials
Angioedemas, Hereditary 4
Angioedema 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for berotralstat hydrochloride

Trials by Country

Trials by Country for berotralstat hydrochloride
Location Trials
United States 19
Canada 3
Spain 2
Romania 2
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for berotralstat hydrochloride
Location Trials
Washington 1
Texas 1
Pennsylvania 1
Oregon 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for berotralstat hydrochloride

Clinical Trial Phase

Clinical Trial Phase for berotralstat hydrochloride
Clinical Trial Phase Trials
Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for berotralstat hydrochloride
Clinical Trial Phase Trials
Not yet recruiting 3
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for berotralstat hydrochloride

Sponsor Name

Sponsor Name for berotralstat hydrochloride
Sponsor Trials
BioCryst Pharmaceuticals 3
Ionis Pharmaceuticals, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for berotralstat hydrochloride
Sponsor Trials
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.